Table 3.
Comparison of open-field test results at different time points in each group (mean ± SD, score, n = 40).
| Group | Before modeling | After modeling | After administration | |
|---|---|---|---|---|
| Horizontal movement | Blank control | 46.75±6.80 | 43.13±5.91 | 44.00±5.95 |
| Model | 46.50±6.55 | 26.88±5.91∗∗ | 25.88±7.70 | |
| Citalopram | 47.63±11.51 | 27.63±7.23∗∗ | 35.13±8.60∗▲ | |
| Low-dose Chailong Jieyu Pill | 46.38±12.20 | 30.13±8.01∗∗ | 42.75±3.96▲▲○ | |
| High-dose Chailong Jieyu Pill | 44.38±9.12 | 27.13±7.26∗∗ | 43.88±7.26▲▲○ | |
| Vertical movement | Blank control | 11.50±3.21 | 10.00±3.46 | 10.75±4.27 |
| Model | 11.13±2.70 | 5.00±2.27∗∗ | 5.25±2.38 | |
| Citalopram | 10.88±4.36 | 5.75±3.11∗ | 6.88±2.30∗ | |
| Low-dose Chailong Jieyu Pill | 11.38±4.10 | 5.88±2.90∗ | 9.25±3.88▲ | |
| High-dose Chailong Jieyu Pill | 0.88±3.09 | 5.75±3.92∗ | 9.75±2.76▲▲○ |
∗P < 0.05, ∗∗P < 0.01, versus blank control group; ▲P < 0.05, ▲▲P < 0.01, versus model group; ○P < 0.05, versus citalopram group.